Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cutaneous lupus erythematosus
ADR ID BADD_A05422
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.03      Lupus erythematosus and associated conditions
10.04.03.007      Cutaneous lupus erythematosus
15      Musculoskeletal and connective tissue disorders
15.06      Connective tissue disorders (excl congenital)
15.06.02      Lupus erythematosus (incl subtypes)
15.06.02.007      Cutaneous lupus erythematosus
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.02      Connective tissue disorders
23.03.02.008      Cutaneous lupus erythematosus
Description A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID). [MeSH]
MedDRA Code 10056509
MeSH ID D008178
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cutaneous lupus erythematosus | Lupus Erythematosus, Cutaneous | Cutaneous Lupus Erythematosus | Lupus Erythematosus, Subacute Cutaneous | Lupus Erythematosus, Cutaneous, Subacute
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01933Ribavirin0.003956%
BADD_D02010Sertraline0.000013%
BADD_D02026Simvastatin0.000011%
BADD_D02066Spironolactone0.000037%
BADD_D02111Tamoxifen--
BADD_D02112Tamoxifen citrate--
BADD_D02160Terbinafine0.000968%
BADD_D02161Terbinafine hydrochloride--
BADD_D02192Thalidomide0.000820%
BADD_D02329Valproic acid--
BADD_D02369Voriconazole--
The 2th Page    First    Pre   2    Total 2 Pages